2225 Stock Overview
An investment holding company, primarily engages in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Jinhai Medical Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$8.50 |
| 52 Week High | HK$9.44 |
| 52 Week Low | HK$0.78 |
| Beta | 0.052 |
| 11 Month Change | 24.09% |
| 3 Month Change | 75.26% |
| 1 Year Change | 240.00% |
| 33 Year Change | 233.33% |
| 5 Year Change | 434.59% |
| Change since IPO | 1,445.45% |
Recent News & Updates
Jinhai Medical Technology (HKG:2225) Has Debt But No Earnings; Should You Worry?
Nov 05
Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price
Oct 06The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon
Jun 19Recent updates
Jinhai Medical Technology (HKG:2225) Has Debt But No Earnings; Should You Worry?
Nov 05Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price
Oct 06The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon
Jun 19Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%
May 13Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%
Mar 17What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You
Jan 31Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital
Jun 06Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital
Mar 07Shareholder Returns
| 2225 | HK Professional Services | HK Market | |
|---|---|---|---|
| 7D | -7.6% | -1.0% | 2.2% |
| 1Y | 240.0% | 37.6% | 17.8% |
Return vs Industry: 2225 exceeded the Hong Kong Professional Services industry which returned 37.6% over the past year.
Return vs Market: 2225 exceeded the Hong Kong Market which returned 17.8% over the past year.
Price Volatility
| 2225 volatility | |
|---|---|
| 2225 Average Weekly Movement | 8.9% |
| Professional Services Industry Average Movement | 7.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 2225 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2225's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 508 | Zhenfei Wang | www.jin-hai.com.hk |
Jinhai Medical Technology Limited, an investment holding company, primarily engages in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. The company also provides dormitory services; information technology services; and construction ancillary services comprising warehousing and cleaning services, and building maintenance works. In addition, it engages in the engineering design and consultancy activities, and accommodation for foreign workers dormitory providers; is involved in the provision of minimally invasive surgery solutions, medical products, and related services, as well as sales of medical equipment; and graphene material products.
Jinhai Medical Technology Limited Fundamentals Summary
| 2225 fundamental statistics | |
|---|---|
| Market cap | HK$10.99b |
| Earnings (TTM) | -HK$58.79m |
| Revenue (TTM) | HK$346.10m |
31.7x
P/S Ratio-186.9x
P/E RatioIs 2225 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2225 income statement (TTM) | |
|---|---|
| Revenue | S$59.60m |
| Cost of Revenue | S$45.20m |
| Gross Profit | S$14.40m |
| Other Expenses | S$24.53m |
| Earnings | -S$10.12m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0078 |
| Gross Margin | 24.17% |
| Net Profit Margin | -16.99% |
| Debt/Equity Ratio | 19.8% |
How did 2225 perform over the long term?
See historical performance and comparison